Ma, Yuanzhen
Fang, Zhiyu
Zhang, Hongning
Qi, Yijun
Mao, Yuke
Zheng, Junfang http://orcid.org/0000-0003-4071-4764
Funding for this research was provided by:
National Natural Science Foundation of China (81974415, 82172923)
Natural Science Foundation of Beijing Municipality (7192021)
Article History
Received: 17 August 2023
Revised: 24 January 2024
Accepted: 25 January 2024
First Online: 12 April 2024
Competing interests
: The authors declare no competing interests.
: The use of TMA microarray for research purposes was approved by the Ethics Committee of Shanghai Outdo Biotech Company. The clinical study conformed to the standard set by the Declaration of Helsinki. All animal experimental procedures were performed following the ‘Guide for the Care and Use of Laboratory Animals’ published by the National Institutes of Health (NIH) and were approved by the Animal Care and Use Committee of Capital Medical University (No. AEEI-2018-010).